As early onset breast/ovarian cancer and the occurrence of multiple primary breast and/ovarian cancers in a single individual adds considerably to the prior probability of a mutation being present, we evaluated the prevalence of BRCA1/2 mutations in patients with these clinical characteristics and no further family history. The gene discussed is BRCA1; the disease is ovarian carcinoma.